Second hepatic resection for recurrent hepatocellular carcinoma in patients with chronic hepatitis C

World Journal of Surgery

Volumn 32, Issue 4, 2008, Pages 632-638

  Kubo, Shoji ^a   Takemura, Shigekazu ^a   Uenishi, Takahiro ^a   Yamamoto, Takatsugu ^a   Ohba, Kazuki ^a   Ogawa, Masao ^a   Hai, Seikan ^a   Ichikawa, Tsuyoshi ^a   Kodai, Shintaro ^a   Shinkawa, Hiroji ^a   Tanaka, Hiromu ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; DIURETIC AGENT; INDOCYANINE GREEN; INTERFERON;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER PATIENT; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HEPATITIS C; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; REOPERATION; RISK FACTOR;

AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; DISEASE-FREE SURVIVAL; FEMALE; HEPATECTOMY; HEPATITIS C, CHRONIC; HUMANS; INTERFERONS; KAPLAN-MEIERS ESTIMATE; LIVER FUNCTION TESTS; LIVER NEOPLASMS; LONGITUDINAL STUDIES; MALE; NEOPLASM RECURRENCE, LOCAL; REOPERATION; TREATMENT OUTCOME;

EID: 41049085569     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-007-9365-z     Document Type: Article

References (29)

1. Kubo S, Nishiguchi S, Shuto T et al. (1999) Effects of continuous hepatitis with persistent hepatitis C viremia on outcome after resection of hepatocellular carcinoma. Jpn J Cancer Res 90:162-170
2. Kubo S, Hirohashi K, Tanaka H et al. (2000) Risk factors for recurrence after resection of hepatitis C virus-related hepatocellular carcinoma. World J Surg 24:1559-1565
3. Kumada T, Nakano S. Takeda I et al. (1997) Patterns of recurrence after initial treatment in patients with small hepatocellular carcinoma. Hepatology 25:87-92
4. Kubo S, Kinoshita H, Hirohashi K et al. (1999) Patterns of and risk factors for recurrence after liver resection for well-differentiated hepatocellular carcinoma: a special reference to multicentric carcinogenesis after operation. Hepatogastroenterology 46:3212-3215
5. Sakon M, Umeshita K, Nagano H et al. (2000) Clinical significance of hepatic resection in hepatocellular carcinoma: analysis by disease-free survival curves. Arch Surg 135:1456-1459
6. Tarao K, Takemiya S, Tamai S et al. (1997) Relationship between the recurrence of hepatocellular carcinoma (HCC) and serum alanine aminotransferase levels in hepatectomized patients with hepatitis C virus-associated cirrhosis and HCC. Cancer 79:688-694
7. Nishiguchi S, Kuroki T, Nakatani S et al. (1995) Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis. Lancet 346:1051-1055
8. Kasahara A, Hayashi N, Mochizuki K et al. (1998) Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C. Hepatology 27:1394-1402
9. Imai Y, Kawata S, Tamura S et al. (1998) Relation of interferon therapy and hepatocellular carcinoma in patients with chronic hepatitis C. Osaka Hepatocellular Carcinoma Prevention Study Group. Ann Intern Med 129:94-99
10. International Interferon-alpha Hepatocellular Carcinoma Study Group (1998) Effect of interferon-alpha on progression of cirrhosis to hepatocellular carcinoma: a retrospective cohort study. Lancet 351:1535-1539
11. Yoshida H, Shiratori Y, Moriyama M et al. (1999) Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. IHIT Study Group. Inhibition of Hepatocarcinogenesis by Interferon Therapy. Ann Intern Med 131:174-181
12. Ikeda K, Saitoh S, Arase Y et al. (1999) Effect of interferon therapy on hepatocellular carcinogenesis in patients with chronic hepatitis type C: a long-term observation study of 1,643 patients using statistical bias correction with proportional hazard analysis. Hepatology 29:1124-1130
13. Ikeda K, Arase Y, Saitoh S et al. (2000) Interferon beta prevents recurrence of hepatocellular carcinoma after complete resection or ablation of the primary tumor-a prospective randomized study of hepatitis C virus-related liver cancer. Hepatology 32:228-232
14. Kubo S, Nishiguchi S, Hirohashi K et al. (2001) Effects of long-term postoperative interferon-α therapy on intrahepatic recurrence after resection of hepatitis C virus-related hepatocellular carcinoma: a randomized, controlled trial. Ann Intern Med 34:963-967
15. Kubo S, Nishiguchi S, Hirohashi K et al. (2002) Randomized clinical trial of long-term outcome after resection of hepatitis C virus-related hepatocellular carcinoma by postoperative interferon therapy. Br J Surg 89:418-422
16. Shiratori Y, Shiina S, Teratani T et al. (2003) Interferon therapy after tumor ablation improves prognosis in patients with hepatocellular carcinoma associated with hepatitis C virus. Ann Intern Med 138:299-306
17. Shuto T, Kinoshita H, Hirohashi K et al. (1996) Indications for, and effectiveness of, a second hepatic resection for recurrent hepatocellular carcinoma. Hepatogastroenterology 43:932-937
18. Shimada M, Takenaka K, Taguchi K et al. (1998) Prognostic factors after repeat hepatectomy for recurrent hepatocellular carcinoma. Ann Surg 227:80-85
19. Nakajima Y, Ko S, Kanamura T et al. (2001) Repeat liver resection for hepatocellular carcinoma. J Am Coll Surg 192:339-344
20. Minagawa M, Makuuchi M, Takayama T et al. (2003) Selection criteria for repeat hepatectomy in patients with recurrent hepatocellular carcinoma. Ann Surg 238:703-710
21. Liver Cancer Study Group of Japan (2003) General rules for the clinical and pathological study of primary liver cancer, 2nd ed. Kanehara & Co, Tokyo
22. Edmondson HA, Steiner PE (1954) Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer 7:462-503
23. Desmet VJ, Gerber M, Hoofnagle JH et al. (1994) Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 19:1513-1520
24. Liver Cancer Study Group of Japan (1990) Primary liver cancer in Japan: Clinicopathological features and results of surgical treatment. Ann Surg 211:277-287
25. Shirabe K, Takenaka K, Taketomi A et al. (1996) Postoperative hepatitis status as a significant risk factor for recurrence in cirrhotic patients with small hepatocellular carcinoma. Cancer 77:1050-1055
26. Kubo S, Nishiguchi S, Hirohashi K et al. (2001) Influence of previous interferon therapy on recurrence after resection of hepatitis C virus-related hepatocellular carcinoma. Jpn J Cancer Res 92:59-66
27. Uenishi T, Kubo S, Hirohashi K et al. (2002) Relationship between response to previous interferon therapy and postoperative recurrence of hepatitis C virus-related hepatocellular carcinoma. Hepatol Res 24:404-412
28. Moreno-Otero R (2005) Therapeutic modalities in hepatitis C: challenges and development. J Virol Hepat 12:10-19
29. Kubo S, Tanaka H, Takemura S et al. (2007) Surgical treatment for hepatocellular carcinoma detected after successful interferon therapy. Surg Today 37:285-290